Design of Diarylheptanoid Derivatives as Dual Inhibitors Against Class IIa Histone Deacetylase and β-amyloid Aggregation

Frontiers in Pharmacology
Liang-Chieh ChenKai-Cheng Hsu

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with multiple etiologies. Beta-amyloid (Aβ) self-aggregation and overexpression of class IIa histone deacetylases (HDACs) are strongly implicated with AD pathogenesis. In this study, a series of novel diarylheptanoid derivatives were designed, synthesized and evaluated for use as dual Aβ self-aggregation and class IIa HDAC inhibitors. Among these compounds, 4j, 5c, and 5e displayed effective inhibitions for Aβ self-aggregation, HDAC5 activity and HDAC7 activity with IC50 values of <10 μM. The compounds contain three common features: (1) a catechol or pyrogallol moiety, (2) a carbonyl linker and (3) an aromatic ring that can function as an HDAC cap and create hydrophobic interactions with Aβ1-42. Furthermore, compounds 4j, 5c, and 5e showed no significant cytotoxicity to human neuroblastoma SH-SY5Y cells and also exhibited neuroprotective effect against H2O2-induced toxicity. Overall, these promising in vitro data highlighted compounds 4j, 5c, and 5e as lead compounds that are worthy for further investigation.

References

Feb 8, 2003·Chemistry & Biology·Dennis WegenerAndreas Schwienhorst
Oct 1, 2003·Proteins·Feng DingNikolay V Dokholyan
Nov 14, 2003·Journal of Medicinal Chemistry·Thomas A MillerSandro Belvedere
Oct 14, 2005·Journal of Medicinal Chemistry·Richard Morphy, Zoran Rankovic
Sep 7, 2006·Nature Reviews. Drug Discovery·Jessica E BoldenRicky W Johnstone
Mar 13, 2010·Circulation Research·Andriana MargaritiLingfang Zeng
Oct 29, 2010·Trends in Pharmacological Sciences·André FischerLi-Huei Tsai
Jul 28, 2011·Medicinal Research Reviews·Rafael LeónJosé Marco-Contelles
Nov 19, 2011·The International Journal of Neuropsychopharmacology·Takenao KosekiToshitaka Nabeshima
Mar 26, 2013·Journal of Clinical Pathology·Barnabas James Gilbert
Mar 12, 2016·Journal of Visualized Experiments : JoVE·Mackenzie M ShipleyMoriah L Szpara
Nov 4, 2016·Frontiers in Neuroscience·Alexandre Vallée, Yves Lecarpentier
May 10, 2017·Frontiers in Neuroscience·Stuart K Calderwood, Ayesha Murshid
Jul 20, 2017·Journal of Biomedical Science·Shih-Ya Hung, Wen-Mei Fu
Aug 16, 2017·European Journal of Medicinal Chemistry·Angela De SimoneAndrea Milelli
Nov 8, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Syed Haris OmarHassan K Obied
Nov 13, 2017·Neuroscience Letters·Natalia MarangoniDouglas L Feinstein

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
column chromatography
Fluorescence

Software Mentioned

DS
Discovery Studio ( DS
DS Macromolecules Tools
CDOKER
CHARMm
CDOCKER

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.